Affiliation:
1. Division of Microbiology, FDA, National Center for Toxicological Research, Jefferson, Arkansas, USA
2. Division of Product Science, FDA, Center for Tobacco Products, Silver Spring, Maryland, USA
Abstract
ABSTRACT
There are an estimated 8 million users of smokeless tobacco products (STPs) in the United States, and yet limited data on microbial populations within these products exist. To better understand the potential microbiological risks associated with STP use, a study was conducted to provide a baseline microbiological profile of STPs. A total of 90 samples, representing 15 common STPs, were purchased in metropolitan areas in Little Rock, AR, and Washington, DC, in November 2012, March 2013, and July 2013. Bacterial populations were evaluated using culture, pyrosequencing, and denaturing gradient gel electrophoresis (DGGE). Moist-snuff products exhibited higher levels of bacteria (average of 1.05 × 10
6
CFU/g STP) and diversity of bacterial populations than snus (average of 8.33 × 10
1
CFU/g STP) and some chewing tobacco products (average of 2.54 × 10
5
CFU/g STP). The most common species identified by culturing were
Bacillus pumilus
,
B. licheniformis
,
B. safensis
, and
B. subtilis
, followed by members of the genera
Oceanobacillus
,
Staphylococcus
, and
Tetragenococcus.
Pyrosequencing analyses of the 16S rRNA genes identified the genera
Tetragenococcus
,
Carnobacterium
,
Lactobacillus
,
Geobacillus
,
Bacillus
, and
Staphylococcus
as the predominant taxa. Several species identified are of possible concern due to their potential to cause opportunistic infections and reported abilities to reduce nitrates to nitrites, which may be an important step in the formation of carcinogenic tobacco-specific N′-nitrosamines. This report provides a microbiological baseline to help fill knowledge gaps associated with microbiological risks of STPs and to inform potential regulations regarding manufacture and testing of STPs.
IMPORTANCE
It is estimated that there 8 million users of smokeless tobacco products (STPs) in the United States; however, there are limited data on microbial populations that exist within these products. The current study was undertaken to better understand the potential microbiological risks associated with STP use and provide a baseline microbiological profile of STPs. Several bacterial species were identified that are of possible concern due to their potential to cause opportunistic infections. In addition, some species have abilities to reduce nitrates to nitrites, which may be an important step in the formation of carcinogenic tobacco-specific N′-nitrosamines. Overall, this report provides a microbiological baseline to help fill knowledge gaps related to the microbiological risks of STPs and to inform potential regulations regarding the manufacture and testing of STPs.
Funder
Center for Tobacco Products, U.S. FDA
Publisher
American Society for Microbiology
Subject
Ecology,Applied Microbiology and Biotechnology,Food Science,Biotechnology
Reference42 articles.
1. Substance Abuse and Mental Health Services Administration. 2010. Results from the 2009 National Survey on Drug Use and Health: detailed tables. Substance Abuse and Mental Health Services Administration, Office of Applied Studies, Rockville, MD.
2. Tobacco use among middle and high school students—United States, 2000–2009;Centers for Disease Control and Prevention;MMWR Morb Mortal Wkly Rep,2010
3. Human pathogens abundant in the bacterial metagenome of cigarettes;Sapkota AR;Environ Health Perspect,2010
4. Microbiology of oral smokeless tobacco products;Cockrell W;Tob Sci,1989
5. National Cancer Institute and Centers for Disease Control and Prevention. 2014. Smokeless tobacco and public health: a global perspective. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Institutes of Health, Bethesda, MD.